Crystal Nance

Wife. Mom. Doing my best one day at a time. Faith and family and way too much coffee ☕

[Paxdor @TrendTrader_Pas]

$AVGO $500c sniped at the bottom lookign to hold everything over 400 from here 410 then 425 are your next spots

[Christophe Belleuvre @belleuvre]

@NCheron_bourse $AAL American Airlines. Le secteur aérien reste détesté par beaucoup d'investisseurs, souvent pour de bonnes raisons. C'est pour ça que je continue à le surveiller. Quand le pessimisme est généralisé, le marché peut parfois offrir des opportunités. Sous résistance.

[Crystal Nance @crystal0563]

$HYPE - regulatory overhang is real. no KYC with US exposure, operating in a China-banned market. structure still holds the weekly level, but this is the kind of news that breaks support fast. tightened stop, watching close.

[GM Club @GMClubNFT]

Attention $AIV Family! YOUR vote matters!

Less than 100 votes are needed to list $AIV on the Moonshot Top 100 Leaderboard.

- Listing ID: 2380

Every vote counts - Moonshot would be huge for community growth.
https://t.co/E0Ny2VYXD3

[Thomas Swanson @z20omassw_anson]

If you’re holding $FE $WBD $AGNC , don’t sleep on this.
👇
@reo_throb
always nails the best breakout setups.
My small account blew up 6X thanks to his leads.

[Koray Chelikhan @KorayChelikhan]

@BullMarketBoss My long term winners have been $NVDA and $AMD

[dan @danstradingco]

@hood__house she needs to stop or $ARKK will never hit ath again 🤦‍♂️😂

[Crystal Nance @crystal0563]

The pull from $CELZ this week surfaces an important question value investors rarely ask about early-stage biotech: what defines the actual floor, and is there a margin of safety at current prices?

Let me work through this carefully, because the name sits in a category that demands intellectual honesty.

The Ultrasome™ platform has generated a 93% efficacy dataset - that's a meaningful signal for a proprietary drug-delivery mechanism if the cohort size holds up under scrutiny. Project PHOENIX is advancing nationwide with an AI-enabled architecture for veteran healthcare, which carries both a political tailwind (government prioritization of veteran outcomes) and a real revenue catalyst if deployment scales. Roth Capital has set a $20 price target - not a number to dismiss; they don't publish micro-cap coverage without doing the diligence.

Now, the other side.

Classic value investing toolkits struggle here. FCF screens return nothing useful when a company is burning cash to fund R&D and clinical expansion. P/E is undefined. EV/EBITDA compresses to meaninglessness at pre-revenue stage. Book value per share may be the closest honest anchor - and at these levels, the gap between stated book and market price tells you how much speculative premium remains baked in even after this pullback.

What the tight float dynamic actually does is create convexity. It is not a substitute for fundamentals. Float compression amplifies volatility in both directions: a strong data release can re-rate the equity fast; a secondary offering or missed milestone can cut just as fast. Value investors should be clear-eyed about which driver they're underwriting before calling a dip an opportunity.

The capital allocation question matters too. How is management deploying cash on the balance sheet? Burns accelerating into catalysts (productive) versus G&A expenses outpacing R&D spend (red flag) - that distinction is everything at this stage. Quarterly balance sheet review is non-negotiable on names like this.

My framework before sizing up: confirmed cash runway of 12+ months (dilution shouldn't be forced), the next Ultrasome™ cohort expanding on the 93% figure rather than just repeating one readout, and clarity on Project PHOENIX's revenue recognition timeline - when does this convert from pipeline narrative to actual free cash flow?

If those three boxes check, intrinsic value likely sits well above current levels and the patience thesis holds. If they don't, the margin of safety is a story, not a floor.

Watching the fundamentals closely. Added to the catalyst tracker this week - not chasing the float, just watching the science and the balance sheet.

[Qi @Qi52430971]

🚀 While you’re sleeping, the market is printing.

I’m a futures trader, sharing my personal high-probability setups and exact entries/exits for free.

#xauusd

🚨Telegram: https://t.co/SlDzSXr2Uj

$YZY $AVGO

Stop watching from the sidelines.

7a5v

[Equity Market Expert @real_stefnay47e]

If you hold the following stocks:

$LYFT $KO $ABEV
For other stock inquiries, please click the link on my homepage to contact me. I have created a WhatsApp group.A 95% accuracy rate will make you the first person in your family to earn 100,000 a month.

[T_SkiTrade @d_onnuand41erw]

Still stuck holding $AGNC $BSX $QXO unsure when a breakout hits?

Message me on WhatsApp to join our trading group.

I deliver vetted breakout setups every trading day.

Last week our group members earned profits $3,600 up to $55,000 following my trade guidance.

[Zero Shorts @zeroshorts]

$TSLA $TSLAQ

[Cyberpunk Sense 👑 @napoleon21st]

One of the big reasons I like Ouster $OUST is that they're partnering with 2 of my favorite companies $AMZN and $FUJIF

I'm a long time Fujifilm camera user for my photography and videography and I can confirm they have the best color science in the world and now it is being used by Ouster to make the best one of a kind Lidar in the world.

[Crystal Nance @crystal0563]

booked $56k today.

wagyu's in the pan, aged whisky's open, and I'm actively trying not to look at my watchlist.

but here's what most people miss about big green days - the danger isn't the loss days. it's the green days. you feel invincible, you start seeing setups everywhere, add size on impulse, and by friday you've handed back half of it to positions that had no business being on.

done that before. not doing it this week.

$SLV calls held over the weekend were the main driver - posted the thesis friday, SLV was compressing against gold's wedge with IV that wasn't pricing the move correctly. SMR calls were the same story: nuclear sentiment wave, options premium cheap relative to the potential move. both worked. sometimes it really is that clean.

now here's where I diverge from most of the room this FOMC week:

i don't front-run the print.

ngl, I've watched too many front-runners get cremated to keep doing it. they load up thursday night, pay inflated IV, and then either get stopped on the initial knee-jerk or whipsawed when price reverses 20 minutes into the presser. structurally it's a bad bet - you're paying premium into the event, fighting time decay, and you need to be right on both direction and magnitude. that's three things that have to go your way simultaneously.

my edge is the reaction trade. the 10-30 minute window after the initial spike or drop - when the knee-jerk exhausts and the market reveals what it actually believes. that's where I want clean entries. defined risk, tight stop below the post-announcement range, and real RR on the move.

until then: sitting on hands.

current book:
- AMZN iron condor - collected premium last week, theta grinding, purely mechanical until I see a reason to adjust
- UNH iron condor - same structure, different risk surface (healthcare policy noise in the background), watching the wings closely
- NOK on watchlist - needs to pull back to the zone I flagged before the week started, not chasing it up here
- AMPG on watchlist - very close to my area of interest, will consider small size if it tags the level

the condors are the quiet part of the book right now. they're just working. I'm not adding delta exposure in front of a major macro event.

one thing worth saying about booking profits and getting green for the month: it matters psychologically even if it doesn't matter mathematically. when you're in the red, you take worse trades - you justify oversized entries, you hold through stops trying to "get it back." the green cushion lets you be patient and selective. now I'm patient and selective.

FOMC reaction is the only thing I'm sizing for this week. if NOK or AMPG come to me at my levels before the print, small entries only. if they don't, fine - there'll be another week.

trade the reaction. not the prediction.

[John Furgele @J3LLY21]

Overall Green Day but not much to do.

Trades today:

$SOXL shorted, -1R
$AMDL shorted, cut breakeven
$TNA shorted, covered 70% throughout day. Stop at b/e

[Stock Analysis Strategies @holly11np8]

If you hold the following stocks:

$AI $ACHC $ASBP
For other stock inquiries, please click the link on my homepage to contact me. I have created a WhatsApp group.We recommend 3-5 potential stocks daily and provide real-time risk warnings.
Friendly global community

[Market Stock Expert @znai_ell78anev]

Still holding $RIG $AUR $CDE ?
Message me on WhatsApp.
I share reliable breakout plays every trading day.
Group members saw gains ranging from $3,200 to $46,000 last week from my recommendations.

[Crystal Nance @crystal0563]

been watching $QBTS structure for weeks - Mizuho PT raise to $35 after analyst day. 10 logical qubits by 2030 roadmap extended. daily needs to hold this level or it's just noise

[🥤𝐁𝐚𝐧𝐤𝐬 @_Afcbanks]

Sweden looked like a serious contender after this thrashing. Gyökeres stepping up like that alongside Isak and the Ayari brace? That’s the kind of performance that gets fans dreaming. Absolute beast of a showing. 🇸🇪🔥

[Crystal Nance @crystal0563]

The Jassy-DC-Anthropic story is being read wrong by most of the crowd posting right now.

WSJ drops this at market open: Amazon's CEO met with U.S. officials, and Anthropic models get restricted in the wake of those conversations. The reflexive take - Jassy cooperated, Claude gets clipped, Amazon hedged its AI bet to stay friendly with DC. Clean story. Incomplete trade.

I've been in $AMZN calls since the June 4 dip. Here's how I'm actually processing this:

First angle - regulatory positioning as moat.

If Jassy is in DC setting the terms of "compliant AI," AWS becomes the enterprise-safe cloud. The CISOs who were nervous about deploying Anthropic models without regulatory clarity - they just got their cover story. "We use AWS Bedrock, the government's already reviewed the guardrails." That's a sales pitch, not a liability. Compliance regimes historically accelerate enterprise cloud consolidation. This isn't inherently a sell signal.

Second angle - the Anthropic equity position is not the same as the Anthropic deployment surface.

Model capability restrictions don't unwind Amazon's multi-billion stake in the company. What they do is constrain where and how Claude gets deployed in certain high-sensitivity verticals. AWS Bedrock still exists. Nova still exists. The crackdown might actually narrow the competitive surface area Anthropic has inside AMZN's own ecosystem - weird kind of internal vertical integration by regulatory default.

Third angle - where I'm actually nervous.

EU contagion is the tail risk nobody's pricing today. If Washington restricts Anthropic model outputs with documented rationale, Brussels will cite that paperwork within 60 days. Fragmented AI compliance by geography is a real operational cost that hits AWS margin - not catastrophically, but enough to slow the re-rate. That's the leg down worth hedging.

Also watching for a second WSJ drop. The first article establishes the fact pattern. If a second piece comes out with named officials and specific model capabilities listed - that's the one that creates sustained selling pressure. Right now this is a "wait and see if the news cycle develops" situation, not a "dump everything" situation.

Current position: AMZN June 200 calls, entered June 4. Not adding above 195. If this news creates a flush toward 190-192, I'll size in more aggressively - that level held twice as support and the AWS margin story hasn't changed.

Stop: close under 188 invalidates the thesis. That's where the pre-earnings base breaks and I don't want to be holding through that.

Momentum read: if AMZN holds 195 intraday on this headline and closes green, the market is pricing DC risk as a feature - compliance moat - not a bug. That's actually constructive for the next leg. If it fails 195 on volume, I want to see where it stabilizes before adding. Don't chase the first bounce.

The RR on these calls still works if you believe the AWS re-rate continues. This WSJ piece changes the narrative texture, not the core AWS growth vector. Wrong to ignore it - also wrong to overreact to it before the second shoe drops.